Advertisement
Screener

Aura Biosciences, Inc. (AURA) ROE

Aura Biosciences, Inc. (AURA) ROE

  • 2026-06-30: ROE -41.56%.
  • 2026-03-31: ROE -104.80%.
  • 2025-12-31: ROE -77.56%.
  • 2025-09-30: ROE -67.96%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-41.56%
2026-03-31-104.80%
2025-12-31-77.56%
2025-09-30-67.96%
2025-06-30-58.05%
2025-03-31-74.00%
2024-12-31-57.19%
2024-09-30-47.64%
2024-06-30-42.14%
2024-03-31-37.67%
2023-12-31-33.83%
2023-09-30-46.69%
2023-06-30-40.99%
2023-03-31-35.17%
2022-12-31-30.05%
2022-09-30-46.79%
2022-06-30-36.23%
2022-03-31-29.88%
2021-12-31-23.14%
2021-09-3021.77%
2021-06-3019.00%
2021-03-3118.06%
2020-12-3120.43%

Annual ROE

DateROE
2025-12-31-77.56%
2024-12-31-57.19%
2023-12-31-33.83%
2022-12-31-30.05%
2021-12-31-23.14%
2020-12-3120.43%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B